0.0000
-4.2600
(-100.00%)
As of May 30 at 8:52:31 AM GMT+2. Market Open.
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
3,724
2,987
9,793
15,718
Total Liabilities Net Minority Interest
2,887
4,590
4,901
5,343
Total Equity Gross Minority Interest
837
-1,603
4,892
10,375
Total Capitalization
837
-1,603
4,892
10,375
Common Stock Equity
837
-1,603
4,892
10,375
Capital Lease Obligations
951
1,315
1,631
1,868
Net Tangible Assets
837
-1,603
4,892
10,375
Working Capital
301
-2,147
4,279
9,769
Invested Capital
837
-1,603
4,892
10,375
Tangible Book Value
837
-1,603
4,892
10,375
Total Debt
951
1,315
1,631
1,868
Share Issued
4,523.8760
1,577.7680
1,338.4510
1,124.7510
Ordinary Shares Number
4,523.8760
1,577.7680
1,338.4510
1,124.7510
12/31/2021 - 11/4/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
0RU9.IL 0RU9.IL,0P0000KJ6A,0
1,147,190.00
0.00%
1HB0.F Scorpius Holdings, Inc.
0.0000
-100.00%
2KZ0.F Kezar Life Sciences, Inc.
3.5000
-1.69%
6DW.F D. Western Therapeutics Institute, Inc.
0.5750
+3.60%
0T20.F Traws Pharma, Inc.
0.0000
-100.00%
2DE0.F Genprex, Inc.
0.0000
-100.00%
APH0.F Ampio Pharmaceuticals, Inc.
3.6200
0.00%
BTTAY Biotest Aktiengesellschaft
24.23
+6.27%
5LH0.F Guard Therapeutics International AB (publ)
1.0200
0.00%
3EE0.F Kancera AB (publ)
0.0838
-8.91%